TrialMedical oncology (Northwood, London, England)2022

Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer.

Thejeswar Nakka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.